We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA Says Gout Drug Uloric Has Increased Death Risk Compared To Alternative

(February 25, 2019, 1:30 PM EST) -- SILVER SPRING, Md. — The Food and Drug Administration on Feb. 21 said it concluded that there is an increased risk of death from the use of Uloric brand febuxostate to...
To view the full article, register now.